Expressions of immunogenic molecules in low-dose radiotherapy-treated human renal clear cell carcinoma 786-0 cells

National Medical Journal of China

Volumn 93, Issue 30, 2013, Pages 2385-2387

  Ma, Zhen Feng ^a   Huang, Jian Ru ^b   Cui, Nai Peng ^a   Wen, Ming ^a   Chen, Bao Ping ^a   Li, Zhang ^a   Zhao, Chun Li ^a  

^a HEBEI UNIVERSITY   (China)

^b NONE

Author keywords

Calreticulin; Immunity, cellular; MHC class I II; Radiotherapy dosage

Indexed keywords

CALRETICULIN; CASPASE 6; MELANIN CONCENTRATING HORMONE RECEPTOR 1;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IRRADIATION; KIDNEY CARCINOMA; LOW ENERGY RADIATION; PROTEIN EXPRESSION; RADIATION DOSE DISTRIBUTION; UPREGULATION;

CALRETICULIN; CARCINOMA, RENAL CELL; GENES, MHC CLASS I; GENES, MHC CLASS II; HUMANS; RADIOTHERAPY DOSAGE; TUMOR CELLS, CULTURED;

EID: 84883359769     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.30.012     Document Type: Article

References (5)

1. Dunn G P, Old L J, Schreiber R D. The immunobiology of cancer immune-surveillance and immunoediting. Immunity, 2004, 21: 137-148.
2. Chouaib S. Tumor escape from the immune response: a major hurdle for successful immunotherapy of cancer? Tunis Med, 2005, 83:7-10.
3. Gardai S J, McPhillips K A, Frasch S C, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell, 2005, 123: 321-334.
4. Obeid M. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin. J Immunol, 2008, 181:2533-2543.
5. Obeid M. ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin. J Immunol, 2008, 181: 2533-2543.